Skip to main content
Clinical Trials/NCT03165084
NCT03165084UnknownNot Applicable

iSMS: Person-centred Interactive Self-management Support in Primary Healthcare for People With Type 2 Diabetes - A Randomized Controlled Trial

Umeå University1 site in 1 country140 target enrollmentStarted: May 5, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
140
Locations
1
Primary Endpoint
HbA1c

Study Overview

Brief Summary

The aim of this study is to develop and evaluate a person-centred digital intervention in primary healthcare for people with T2D, in addition to their usual diabetes care.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Diagnosed with type 2 diabetes within the last five years
  • •18 years of age or older
  • •Ability to read and communicate in Swedish
  • •Own a smart phone

Exclusion Criteria

  • •81 years and over at inclusion
  • •Life-threatening physical illness (e.g. cancer)
  • •Documented cognitive impairment
  • •Those not responsible for their own self care
  • •Those not residing in their own home environment (e.g. those in nursing homes, in-patient hospital wards)

Arms & Interventions

Intervention arm

Experimental

Participants in the intervention group will receive usual care, and also use a diabetesapp and a homepage and advice personally tailored according to the personal needs to provide support for them to manage e.g. food choices, exercise, medicine, blood sugars and emotional adaptation.

Intervention: Intervention arm: Person-centred interactive self-management support (Behavioral)

Control arm

Other

Participants in the control group will receive usual care and also take part in a minimal intervention in the form of a brochure on the importance of self-management in diabetes.

Intervention: Control arm (Other)

External comparison group

Other

An external comparison group will be recruited from two other primary health care centers in order to analyse possible Hawthorne effects.

Intervention: External comparison group (Other)

Outcomes

Primary Outcomes

HbA1c

Time Frame: Baseline, 6 months, and 12 months

Change from baseline in HbA1c at 6 months and 1 year (in mmol/mol)

Secondary Outcomes

  • Lifestyle habits - smoking(Baseline, 6 months, and 12 months)
  • Medical treatment(Baseline, 6 months, and 12 months)
  • Illness perception(Baseline, 6 months, and 12 months)
  • Systolic blood pressure(Baseline, 6 months, and 12 months)
  • Diabetes-dependent QoL(Baseline, 6 months, and 12 months)
  • Body Mass Index(Baseline, 6 months, and 12 months)
  • Waist circumference(Baseline, 6 months, and 12 months)
  • Cholesterol, total, LDL and HDL(Baseline, 6 months, and 12 months)
  • Diabetes empowerment(Baseline, 6 months, and 12 months)
  • eHealth literacy(Baseline, 6 months, and 12 months)
  • Lifestyle habits - physical activity(Baseline, 6 months, and 12 months)
  • Lifestyle habits - diet(Baseline, 6 months, and 12 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ulrika Öberg

MSc, PhD student

Umeå University

Study Sites (1)

Loading locations...

Similar Trials